Limited Utility of Serum Hepcidin as a Marker for Erythropoiesis‐Stimulating Agent Hyporesponsiveness in Hemodialysis Patients: An Analysis From the <scp>INFINITY</scp> Cohort
Hepcidin-25 levels were lower in ESA hyporesponsive patients; however, the association was not significant in multivariable analysis. Thus, routine measurement of hepcidin may not be necessary for diagnosing ESA hyporesponsiveness. The novel association between hepcidin and glycoalbumin suggests an interaction between iron regulation and glucose metabolism, warranting further study.
Authors
- Hiroki Hill Kobayashi (ORCID: https://orcid.org/0000-0002-9674-0374)
- Takashi Maruyama (ORCID: https://orcid.org/0000-0003-0820-3219)
- Masanori Yasuo (ORCID: https://orcid.org/0000-0003-3779-728X)
- Masanori Abe
- Akiko Tsunemi
- Tetsuo Tagami
- Hyoe Tomita (ORCID: https://orcid.org/0000-0003-4394-1911)
- Tomomi Matsuoka (ORCID: https://orcid.org/0009-0002-4059-4707)
- Chinami Nagura
- Yoshihiro Nakamura (ORCID: https://orcid.org/0000-0003-1130-538X)
- Noriaki Maruyama
Institutions
- Nihon University (JP)
- Osaka Nishi Clinic (JP)
- Nishijin Hospital (JP)
Publication Details
- Journal
- Therapeutic Apheresis and Dialysis
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1111/1744-9987.70040
- Citations
- 1
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.77